Kauppalehti4h
Idorsia is advancing the treatment of hypertension with new data at the 2024 American Heart Association (AHA) Scientific Sessions
Idorsia Ltd (SIX: IDIA) today announced that new data on aprocitentan, the first-and-only dual endothelin receptor antagonist (ERA) for the treatment of systemic hypertension, will be presented at the ...
Kauppalehti12h
Telia Company: Telia announces tender offer and proposal in respect of certain outstanding GBP notes
Telia Company AB ("Telia") has today announced separate invitations to: (i) holders (the "Noteholders") of its £400,000,000 4.375 per cent. Notes due 5 December 2042 (ISIN: XS0861990173) (the "Notes") ...
Kauppalehti12h
OPEN Health Presents First Collection of Research Backed by Scientific Buyout Fund to Foster Research and Development
Our Scientific Buyout Program reflects our dedication to fostering a culture of scientific excellence and collaboration,” said Professor Ben van Hout, Scientific Founder, OPEN Health HEOR & Market ...
Kauppalehti11h
Jeroen Lokerse appointed CEO of Colliers Netherlands
AMSTERDAM, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Leading global diversified professional services company Colliers announced the appointment of Jeroen Lokerse as CEO of the Netherlands. Lokerse will be ...
Kauppalehti11h
Establishment agreement signing ceremony of the world's first International Mangrove Center held in Shenzhen
SHENZHEN, China, Nov. 11, 2024 (GLOBE NEWSWIRE) -- An agreement on the establishment of the International Mangrove Center (IMC) was officially signed on November 6 in Shenzhen, south China's Guangdong ...
Kauppalehti21h
Concentrix to share new insights on AI and intelligent experiences at Web Summit 2024
Chris Caldwell, President and CEO of Concentrix, to discuss AI's transformative impact on the customer experience Company to showcase leading-edge technologies at Stand 0404-16, FIL1 Pavilion 1 NEWARK ...
Kauppalehti13h
World exhibition organisers confirm confidence in Thailand’s strong potential as exhibition destination
The recent Exhibition Industry Summit 2024’s theme “See Tomorrow Now” was intended for delegates and participants to clearly envision future business opportunities in Thailand. The insights attendee ...
Kauppalehti13h
EnteroBiotix Announces Positive Ph1b Clinical Results of EBX-102 in Liver Cirrhosis
Glasgow, Scotland – 11 November 2024. EnteroBiotix Limited (‘EnteroBiotix’ or the ‘Company’), a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome ...
Kauppalehti1d
Tenaris to Commence a USD 700 million Share Buyback Program
LUXEMBOURG, Nov. 10, 2024 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris”) announced today that pursuant to its USD700 million Share Buyback Program (the “Program” ...
Kauppalehti3d
PTV Logistics Wins Eco Performance Award for the Groundbreaking EV Truck Route Planner
KARLSRUHE, Germany, Nov. 08, 2024 (GLOBE NEWSWIRE) -- PTV Logistics, a global leader in innovative transportation and logistics solutions, was awarded the prestigious Eco Performance Award for its EV ...
Kauppalehti3d
Akari Therapeutics Announces Shareholder Approval in Connection With Peak Bio, Inc. Merger | Kauppalehti
Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, announces shareholder approval in connection with ...
Kauppalehti3d
Teva to Present at the Jefferies London Healthcare Conference
TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the ...